Published in Am J Ind Med on January 01, 2005
Environmental risk factors of pregnancy outcomes: a summary of recent meta-analyses of epidemiological studies. Environ Health (2013) 1.28
Occupational exposure to organic solvent mixtures during pregnancy and the risk of non-syndromic oral clefts. Occup Environ Med (2006) 1.13
Parental occupational exposures and autism spectrum disorder. J Autism Dev Disord (2012) 0.86
Congenital anomalies in newborns to women employed in jobs with frequent exposure to organic solvents--a register-based prospective study. BMC Pregnancy Childbirth (2011) 0.83
Male-mediated developmental toxicity. Asian J Androl (2013) 0.81
Paternal occupation and birth defects: findings from the National Birth Defects Prevention Study. Occup Environ Med (2012) 0.77
Adverse reproductive outcomes among male painters with occupational exposure to organic solvents. Occup Environ Med (2006) 0.77
A case study on co-exposure to a mixture of organic solvents in a Tunisian adhesive-producing company. J Occup Med Toxicol (2011) 0.76
Investigating paternal preconception risk factors for adverse pregnancy outcomes in a population of internet users. Reprod Health (2016) 0.75
Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42
Systematic review and meta-analysis of the effect of warming local anesthetics on injection pain. Ann Emerg Med (2011) 2.33
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ (2003) 2.18
Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther (2002) 2.18
The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol (2009) 2.03
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry (2008) 2.01
Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother (2007) 1.90
Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. Gastroenterology (2010) 1.80
Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch Pediatr Adolesc Med (2004) 1.77
Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can (2009) 1.76
Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother (2007) 1.64
Collaborative medication management in a team-based primary care practice: an explanatory conceptual framework. Res Social Adm Pharm (2005) 1.50
Clinical and cost implications of target joints in Canadian boys with severe hemophilia A. J Pediatr (2004) 1.50
Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother (2008) 1.48
Patterns of paediatric analgesic use in Africa: a systematic review. Arch Dis Child (2012) 1.42
Treatments for metastatic melanoma: synthesis of evidence from randomized trials. Cancer Treat Rev (2007) 1.37
Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department. BMJ (2004) 1.35
Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf (2004) 1.21
Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDS (2004) 1.20
Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother (2002) 1.18
Depression during Pregnancy : Overview of Clinical Factors. Clin Drug Investig (2004) 1.18
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin (2007) 1.17
Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada. AIDS Patient Care STDS (2003) 1.14
Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry (2006) 1.13
Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials. Curr Med Res Opin (2006) 1.12
Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother (2005) 1.12
Intratympanic gentamicin for Menière's disease: a meta-analysis. Laryngoscope (2004) 1.10
Reference values for hair cotinine as a biomarker of active and passive smoking in women of reproductive age, pregnant women, children, and neonates: systematic review and meta-analysis. Ther Drug Monit (2007) 1.06
Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder. Curr Med Res Opin (2004) 1.02
Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry (2009) 1.01
The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program. Curr Med Res Opin (2007) 0.99
Management and prevention of diabetic foot ulcers and infections: a health economic review. Pharmacoeconomics (2008) 0.98
Health state utilities and quality of life in patients with hepatitis B. Can J Gastroenterol (2012) 0.97
Meta-analysis of placebo rates in major depressive disorder trials. Ann Pharmacother (2003) 0.97
Economic burden of nausea and vomiting of pregnancy in the USA. J Popul Ther Clin Pharmacol (2013) 0.96
Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada. Vaccine (2004) 0.96
Cost-of-illness study of type 2 diabetes mellitus in Colombia. Rev Panam Salud Publica (2009) 0.95
Statistics in the pharmacy literature. Ann Pharmacother (2004) 0.94
Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies. Value Health (2008) 0.94
Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder. Clin Ther (2009) 0.91
Economic evaluation of Avonex (interferon beta-Ia) in patients following a single demyelinating event. Mult Scler (2005) 0.91
Seroprevalence of Toxoplasma gondii infection among veterinary staff in Ontario, Canada (2002): implications for teratogenic risk. BMC Infect Dis (2003) 0.89
Direct health care costs of 4 common skin ulcers in New Mexico Medicaid fee-for-service patients. Adv Skin Wound Care (2004) 0.88
Willingness to pay for inhaled insulin: a contingent valuation approach. Pharmacoeconomics (2005) 0.88
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden. Nord J Psychiatry (2013) 0.88
Longitudinal trends in antiretroviral use in a cohort of men and women in Ontario, Canada. AIDS Patient Care STDS (2006) 0.87
Quality assessment of published health economic analyses from South America. Ann Pharmacother (2006) 0.87
Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials. Ann Pharmacother (2005) 0.87
Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence. Am J Clin Dermatol (2004) 0.85
A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium. Clin Ther (2005) 0.85
Polypharmacy in HIV: impact of data source and gender on reported drug utilization. AIDS Patient Care STDS (2004) 0.85
Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada. Pain Res Manag (2007) 0.84
Cost of glaucoma in Canada: analyses based on visual field and physician's assessment. J Glaucoma (2003) 0.84
Quality of structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association: a 10-year follow-up study. Curr Med Res Opin (2005) 0.83
Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Pharmacotherapy (2009) 0.83
Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria. Curr Med Res Opin (2004) 0.83
International drug price comparisons: quality assessment. Rev Panam Salud Publica (2011) 0.82
Medication utilization and illness management study in Nigeria. Ann Pharmacother (2011) 0.81
Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorder. Can J Psychiatry (2012) 0.81
Cost-effectiveness analysis of escitalopram compared with paroxetine in treatment of generalized anxiety disorder in the United Kingdom. Ann Pharmacother (2006) 0.81
Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece. Ann Gen Psychiatry (2012) 0.80
A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK. Curr Med Res Opin (2005) 0.80
Cost impact of switching histamine(2)-receptor antagonists to nonprescription status. Ann Pharmacother (2002) 0.80
Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression. Ann Pharmacother (2004) 0.80
Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study. Neurology (2013) 0.79
Objective assessment of an ionic footbath (IonCleanse): testing its ability to remove potentially toxic elements from the body. J Environ Public Health (2011) 0.79
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report. J Clin Psychiatry (2012) 0.79
Clinical pharmacy services in the home: Canadian case studies. J Am Pharm Assoc (Wash) (2002) 0.78
Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation. Am J Obstet Gynecol (2004) 0.78
An analysis of potentially prolactin-related adverse events and abnormal prolactin values in randomized clinical trials with paliperidone palmitate. Ann Pharmacother (2012) 0.78
HOPE study impact on ACE inhibitors use. Ann Pharmacother (2003) 0.77
Association between mean intraocular pressure, disease stability and cost of treating glaucoma in Canada. Curr Med Res Opin (2004) 0.77
Contribution of Latin America to pharmacovigilance. Ann Pharmacother (2006) 0.77
Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, Canada. Paediatr Drugs (2005) 0.77
Utilities for asthma and COPD according to category of severity: a comprehensive literature review. J Med Econ (2015) 0.77
Out-of-pocket expenditures and coping strategies for people living with HIV: Bogotá, Colombia, 2009. AIDS Care (2011) 0.77
A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom. Clin Ther (2005) 0.77
The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analyses. Pharmacoeconomics (2007) 0.77
Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland. J Med Econ (2013) 0.77
The effectiveness of Proctofoam-HC for treatment of hemorrhoids in late pregnancy. J Obstet Gynaecol Can (2009) 0.76
Nausea and vomiting of pregnancy (NVP) and depression: cause or effect? Clin Invest Med (2011) 0.76
Assessing the reporting and scientific quality of meta-analyses of randomized controlled trials of treatments for anxiety disorders. Ann Pharmacother (2008) 0.76
Cost-effectiveness of escitalopram for generalized anxiety disorder in Canada. Curr Med Res Opin (2008) 0.76
Economic impact of the introduction of an acellular pertussis vaccine in Canada: a 6-year analysis. Vaccine (2009) 0.76
Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease. Pharmacoeconomics (2003) 0.76
Cost analysis of secondary prophylaxis with oral clodronate versus pamidronate in metastatic breast cancer patients. Support Care Cancer (2004) 0.75
Problems with maternal antidepressant treatment and neonatal outcomes study. Arch Gen Psychiatry (2007) 0.75
Assessment of the bioequivalence. Clin Ther (2010) 0.75
Depressive symptoms among women screened in obstetrics settings. J Womens Health (Larchmt) (2004) 0.75
Maternal use of antipsychotics in early pregnancy: little evidence of increased risk of congenital malformations. Evid Based Ment Health (2009) 0.75
Economic and clinical comparison of atypical depot antipsychotic drugs for treatment of chronic schizophrenia in the Czech Republic. J Med Econ (2013) 0.75
Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysis. Curr Med Res Opin (2005) 0.75
Cost comparison of prostaglandin analogues: a Canadian population-based analysis. J Med Econ (2008) 0.75
Validation of an economic model of paliperidone palmitate for chronic schizophrenia. J Med Econ (2013) 0.75
Willingness to pay for a treatment for pain in multiple sclerosis. Pharmacoeconomics (2009) 0.75